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STELLINGEN 
Propositions accompanying the thesis 
 
Discovery of novel Antibiotics from Actinomycetes by 
Integrated Metabolomics & Genomics Approaches 
 
 
1. Lugdunomycin is an angucycline-derived molecule with 
unprecedented chemical scaffold, and its underlying biosynthetic 
logic could be explored to generate a range of novel compounds 
(this thesis). 
 
2. Despite the extensive high-throughput screening by the 
pharmaceutical industry, it is still possible to discover molecules 
with a new chemical skeleton, even using low-throughput methods 
(this thesis). 
 
3. The study of natural products is entering a renaissance, and 
genome-mining is one of the major trends for future antibiotic 
discovery (this thesis). 
 
4. The new concept “Genometabolomics” explores the 
complementarity between “Genomics” and “Metabolomics” 
approaches for natural products discovery (this thesis). 
 
5. In the post-genomics era, a natural product chemist committed to 
discover new antibiotics from microbes, should comprehend both 
the appropriate chemical knowledge and the practical genetic tools 
(this thesis). 
 
6. For antibiotics there is no such thing as "no resistance" (Ling et al., 
Nature 517, 455-459). 
 
7. Antibiotics have helped us to conquer many life-threatening 
infectious diseases, but their adverse effects on the gut microbiome 
should be a major concern (Faber et al., Nature 534, 697–699). 
 
8. Nature always knows best and it might be wise to follow 
“ecology-inspired” approaches for antibiotic discovery, in view of 
the tremendous biodiversity on the earth. 
 
9. The fact is the most delicate forever. 
 
10. It’s important to learn how to find advantage in disadvantage, never 
to lose confidence when “negative results” happen, and find a way 
out. 
 
11. A good reviewer should be the mentor of a manuscript, not a 
criticaster. 
